SDZXF (Sandoz Group AG) Revenue: $11,157 Mil (TTM As of Dec. 2025)


SDZXF Sandoz Group AG SDZXF
18 GF Score
Price $89.55
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Revenue?

Sandoz Group AG SDZXF 18 Revenue is $11,157 Mil as of Dec. 2025. GuruFocus rates SDZXF with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's revenue for the six months ended in Dec. 2025 was $5,892 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $11,157 Mil. Sandoz Group AG's Revenue per Share for the six months ended in Dec. 2025 was $13.46. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $25.54.

Warning Sign:

Sandoz Group AG revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Sandoz Group AG was -4.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Sandoz Group AG's highest 3-Year average Revenue per Share Growth Rate was 0.40% per year. The lowest was 0.40% per year. And the median was 0.40% per year.

Sandoz Group AG  (OTCPK:SDZXF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Sandoz Group AG Revenue Related Terms

Sandoz Group AG Revenue Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Revenue Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Revenue
9,306.00 9,979.00 10,384.00 11,157.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial 5,049.00 5,062.00 5,322.00 5,265.00 5,892.00

SDZXF vs ZTS, UTHR, VTRS: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Revenue distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Revenue falls into.


SDZXF
18GF Score
Sandoz Group AG SDZXF
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $11,157 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $11,157 Mil mean?
Sandoz Group AG (SDZXF) has a Revenue of $11,157 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Revenue too high?
Sandoz Group AG's current Revenue is $11,157 Mil. Overall, Sandoz Group AG has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Revenue compare to ZTS and UTHR?
Sandoz Group AG's Revenue of $11,157 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Revenue is $11,157 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (SDZXF) has a current Revenue of $11,157 Mil. The current Revenue is $11,157 Mil. Sandoz Group AG's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Revenue is $11,157 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
18GF Score

Get the complete analysis for SDZXF

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.55
Price